Associations among the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation.

[1]  T. Chao,et al.  Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. , 2010, The American journal of cardiology.

[2]  W. Ghali,et al.  Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. , 2010, The American journal of cardiology.

[3]  L. Lo,et al.  The Impact of Age on the Electroanatomical Characteristics and Outcome of Catheter Ablation in Patients with Atrial Fibrillation , 2010, Journal of cardiovascular electrophysiology.

[4]  T. Kawamoto,et al.  Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation. , 2010, The American journal of cardiology.

[5]  L. Lo,et al.  Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. , 2010, The American journal of cardiology.

[6]  L. Lo,et al.  The Impact of Left Atrial Size on Long‐Term Outcome of Catheter Ablation of Chronic Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.

[7]  L. Lo,et al.  Acute Effect of Circumferential Pulmonary Vein Isolation on Left Atrial Substrate , 2009, Journal of cardiovascular electrophysiology.

[8]  L. Lo,et al.  Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. , 2009, Heart rhythm.

[9]  L. Lo,et al.  Biatrial Substrate Properties in Patients with Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[10]  L. Lo,et al.  The Efficacy of Inducibility and Circumferential Ablation with Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[11]  David Tamborero,et al.  Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. , 2007, European heart journal.

[12]  L. Lo,et al.  Progressive Remodeling of the Atrial Substrate—A Novel Finding from Consecutive Voltage Mapping in Patients with Recurrence of Atrial Fibrillation After Catheter Ablation , 2007, Journal of cardiovascular electrophysiology.

[13]  C. Tai,et al.  Catheter ablation of atrial fibrillation originating from extrapulmonary vein areas: Taipei approach. , 2006, Heart rhythm.

[14]  R. Hendel,et al.  ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. , 2005, Journal of the American College of Cardiology.

[15]  H. Calkins,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[16]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[17]  Wen-Chung Yu,et al.  Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy , 2003, Circulation.

[18]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[19]  Wen-Chung Yu,et al.  Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. , 2000, Circulation.

[20]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.